Cargando…

Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids

In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major a...

Descripción completa

Detalles Bibliográficos
Autores principales: Koroknai, Viktoria, Patel, Vikas, Szász, István, Ádány, Róza, Balazs, Margit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471197/
https://www.ncbi.nlm.nih.gov/pubmed/32613561
http://dx.doi.org/10.1007/s12253-020-00837-9
_version_ 1783578733843578880
author Koroknai, Viktoria
Patel, Vikas
Szász, István
Ádány, Róza
Balazs, Margit
author_facet Koroknai, Viktoria
Patel, Vikas
Szász, István
Ádány, Róza
Balazs, Margit
author_sort Koroknai, Viktoria
collection PubMed
description In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major aim was to compare the gene expression signature of 2D and 3D cultured BRAFV600E mutant melanoma cell lines. We successfully developed BRAF-drug resistant cell lines from paired primary/metastatic melanoma cell lines in both 2D and 3D in vitro cultures. Using Affymetrix Human Gene 1.0 ST arrays, we determined the gene expression pattern of all cell lines. Our analysis revealed 1049 genes (562 upregulated and 487 downregulated) that were differentially expressed between drug-sensitive cells grown under different cell cultures. Pathway analysis showed that the differently expressed genes were mainly associated with the cell cycle, p53, and other cancer-related pathways. The number of upregulated genes (72 genes) was remarkably fewer when comparing the resistant adherent cells to cells that grow in 3D, and were associated with cell adhesion molecules and IGF1R signalling. Only 1% of the upregulated and 5.6% of the downregulated genes were commonly altered between the sensitive and the resistant spheroids. Interestingly, we found several genes (BNIP3, RING1 and ABHD4) with inverse expression signature between sensitive and resistant spheroids, which are involved in anoikis resistance and cell cycle regulation. In summary, our study highlights gene expression alterations that might help to understand the development of acquired resistance in melanoma cells in tumour tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12253-020-00837-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7471197
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-74711972020-09-16 Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids Koroknai, Viktoria Patel, Vikas Szász, István Ádány, Róza Balazs, Margit Pathol Oncol Res Original Article In vitro cell cultures are frequently used to define the molecular background of drug resistance. The majority of currently available data have been obtained from 2D in vitro cultures, however, 3D cell culture systems (spheroids) are more likely to behave similarly to in vivo conditions. Our major aim was to compare the gene expression signature of 2D and 3D cultured BRAFV600E mutant melanoma cell lines. We successfully developed BRAF-drug resistant cell lines from paired primary/metastatic melanoma cell lines in both 2D and 3D in vitro cultures. Using Affymetrix Human Gene 1.0 ST arrays, we determined the gene expression pattern of all cell lines. Our analysis revealed 1049 genes (562 upregulated and 487 downregulated) that were differentially expressed between drug-sensitive cells grown under different cell cultures. Pathway analysis showed that the differently expressed genes were mainly associated with the cell cycle, p53, and other cancer-related pathways. The number of upregulated genes (72 genes) was remarkably fewer when comparing the resistant adherent cells to cells that grow in 3D, and were associated with cell adhesion molecules and IGF1R signalling. Only 1% of the upregulated and 5.6% of the downregulated genes were commonly altered between the sensitive and the resistant spheroids. Interestingly, we found several genes (BNIP3, RING1 and ABHD4) with inverse expression signature between sensitive and resistant spheroids, which are involved in anoikis resistance and cell cycle regulation. In summary, our study highlights gene expression alterations that might help to understand the development of acquired resistance in melanoma cells in tumour tissue. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12253-020-00837-9) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-07-01 2020 /pmc/articles/PMC7471197/ /pubmed/32613561 http://dx.doi.org/10.1007/s12253-020-00837-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Koroknai, Viktoria
Patel, Vikas
Szász, István
Ádány, Róza
Balazs, Margit
Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title_full Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title_fullStr Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title_full_unstemmed Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title_short Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
title_sort gene expression signature of braf inhibitor resistant melanoma spheroids
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471197/
https://www.ncbi.nlm.nih.gov/pubmed/32613561
http://dx.doi.org/10.1007/s12253-020-00837-9
work_keys_str_mv AT koroknaiviktoria geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids
AT patelvikas geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids
AT szaszistvan geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids
AT adanyroza geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids
AT balazsmargit geneexpressionsignatureofbrafinhibitorresistantmelanomaspheroids